Phase II Study of Dasatinib in Non Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2013
At a glance
- Drugs Dasatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Apr 2012 Actual end date (1 Mar 2012) added as reported by ClinicalTrials.gov.
- 03 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.